Home
HelpTest ID OVAWA Ovarian Mass Risk Monitoring, OvaWatch, Serum
Ordering Guidance
OvaWatch is intended for use as a non-invasive test to assess the risk of ovarian cancer for women with adnexal masses evaluated by initial clinical assessment as indeterminate or benign.
Shipping Instructions
1. Specimens sent refrigerated must reach Mayo Clinic Laboratories within 4 days of collection.
2. Specimens sent frozen must be shipped on dry ice.
Specimen Required
Collection Container/Tube: Sarstedt Aliquot Tube, 5 mL (T914)
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 2 mL Serum
Collection Information:
1. Allow the specimen to clot for at least 30 minutes.
2. Within 2 hours of collection, centrifuge the specimen.
3. For serum gel tubes, aliquot serum into a plastic vial or send centrifuged serum gel tube.
4. For red top tubes, aliquot serum into a plastic vial within 10 minutes of centrifugation.
Useful For
Serial monitoring and risk assessment for ovarian malignancy in women who present with an adnexal mass clinically assessed as indeterminate or benign
Highlights
OvaWatch is a non-invasive lab blood test to determine the risk of ovarian cancer in conjunction with clinical assessment for patients with an adnexal mass. OvaWatch utilizes a neural network-based algorithm combining serum biomarkers and clinical covariates (CA-125 II, prealbumin, apolipoprotein A1, beta2-microglobulin, transferrin, follicle-stimulating hormone, human epididymis protein 4, age and menopausal status) to examine malignancy risk with individuals with an adnexal mass.
Testing Algorithm
For information see Clinical Triage for Adnexal Masses
Method Name
Immunoassay/Multivariate Index Assay/Electrochemiluminescence Immunoassay (ECLIA)
Reporting Name
OvaWatch, SSpecimen Type
SerumSpecimen Minimum Volume
Serum 1.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 8 days |
| Frozen | 90 days |
Reference Values
An interpretive report will be provided
Day(s) Performed
Monday, Wednesday, Friday
Report Available
5 daysPerforming Laboratory
Aspira Labs, Inc.Test Classification
This test was developed and its performance characteristics were determined by Aspira Laboratory. The test has not been cleared or approved by the FDA, nor is it required to be. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. The results represent individual analyses for the patient and were obtained from this multivariate index assay should always be interpreted in the context of clinical examination, patient medical history, and other findings.CPT Code Information
0375U
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| OVAWA | OvaWatch, S | Not Provided |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| OVAWR | OvaWatch | Not Provided |